Cytori and BARDA Execute $13.4 Million Contract Option for Burn Clinical Trial
May 31, 2017 13:05 pm UTC| Business
SAN DIEGO, May 31, 2017 -- Cytori Therapeutics, Inc.(NASDAQ:CYTX) (“Cytori” or the “Company”) today announced that the Company andthe Biomedical Advanced Researchand Development Authority (BARDA), a division of theU.S....
Cytori and BARDA Execute $13.4 Million Contract Option for Burn Clinical Trial
May 31, 2017 13:05 pm UTC| Business
SAN DIEGO, May 31, 2017 -- Cytori Therapeutics, Inc.(NASDAQ:CYTX) (“Cytori” or the “Company”) today announced that the Company andthe Biomedical Advanced Researchand Development Authority (BARDA), a division of theU.S....
Cytori and BARDA Execute $13.4 Million Contract Option for Burn Clinical Trial
May 31, 2017 13:05 pm UTC| Business
SAN DIEGO, May 31, 2017 -- Cytori Therapeutics, Inc.(NASDAQ:CYTX) (“Cytori” or the “Company”) today announced that the Company andthe Biomedical Advanced Researchand Development Authority (BARDA), a division of theU.S....
May 31, 2017 13:04 pm UTC| Business
OXNARD, Calif., May 31, 2017 -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that the CURE and...
May 31, 2017 13:04 pm UTC| Business
OXNARD, Calif., May 31, 2017 -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that the CURE and...
May 31, 2017 13:04 pm UTC| Business
OXNARD, Calif., May 31, 2017 -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that the CURE and...
May 31, 2017 13:04 pm UTC| Business
ROCKVILLE, Md., May 31, 2017 -- American Gene Technologies International Inc. (AGT), a gene technology company with a broad and robust lentiviral delivery platform, today announced that Jeff Galvin, CEO, will present at...
US–India Trade Turbocharge: Stocks Poised to Ride the Export Wave